Eruptive milia during isotretinoin therapy.

MedStar author(s):
Citation: Pediatric Dermatology. 34(6):728-729, 2017 Nov.PMID: 28940619Institution: MedStar Washington Hospital CenterDepartment: Dermatology | Medicine/Internal MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Acne Vulgaris/dt [Drug Therapy] | *Dermatologic Agents/ae [Adverse Effects] | *Exanthema/ci [Chemically Induced] | *Isotretinoin/ae [Adverse Effects] | Adolescent | Dermatologic Agents/tu [Therapeutic Use] | Humans | Isotretinoin/tu [Therapeutic Use] | MaleYear: 2017ISSN:
  • 0736-8046
Name of journal: Pediatric dermatologyAbstract: Isotretinoin (13-cis-retinoic acid) is a synthetic vitamin A derivative that is effective in the treatment of recalcitrant, nodulocystic acne. To our knowledge, there are no reports in the medical literature of milia as a side effect of isotretinoin. We report a case of eruptive facial milia in the setting of isotretinoin treatment for acne. Copyright (c) 2017 Wiley Periodicals, Inc.All authors: Cheng K, Farmer W, Marathe KFiscal year: FY2018Digital Object Identifier: ORCID: Date added to catalog: 2017-09-29
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 28940619 Available 28940619

Isotretinoin (13-cis-retinoic acid) is a synthetic vitamin A derivative that is effective in the treatment of recalcitrant, nodulocystic acne. To our knowledge, there are no reports in the medical literature of milia as a side effect of isotretinoin. We report a case of eruptive facial milia in the setting of isotretinoin treatment for acne. Copyright (c) 2017 Wiley Periodicals, Inc.

English

Powered by Koha